20050970|t|Resveratrol reduces glutamate-mediated monocyte chemotactic protein-1 expression via inhibition of extracellular signal-regulated kinase 1/2 pathway in rat hippocampal slice cultures.
20050970|a|Published evidence has linked glutamate with the pathogenesis of Alzheimer's disease (AD) and the up-regulation of a variety of chemokines, including monocyte chemotactic protein-1 (MCP-1)/chemokine ligand 2, with AD-associated pathological changes. In this study, we assessed the potential molecular basis for the role of glutamate in hippocampal inflammation by determining its effects on MCP-1 induction. We also attempted to identify the mechanism by which resveratrol (trans-3,5,4'-trihydroxystilbene), a polyphenolic phytostilbene, modulates the expression of MCP-1 in the glutamate-stimulated hippocampus. An ex vivo study using rat hippocampal slices demonstrated a time- and dose-dependent increase in MCP-1 release from glutamate-exposed hippocampus. This increase was accompanied by enhanced MCP-1 gene expression via the activation of the MEK/extracellular signal-regulated kinase (ERK) pathway and interleukin-1beta (IL-1beta) expression. The inhibition of the MEK/ERK pathway with SL327, which is capable of crossing the blood-brain barrier, nearly abolished the observed glutamate-induced effects. Furthermore, anti-IL-1beta antibodies suppressed the glutamate-induced expression of MCP-1 mRNA and protein, whereas an isotype-matched antibody exerted only minimal effects. It is worthy of note that resveratrol, to a similar degree as SL327, down-regulated glutamate-induced IL-1beta expression and reduced the expression of MCP-1 mRNA and protein release via the inactivation of ERK1/2. These results indicate that the activation of the MEK/ERK pathway and the consequent IL-1beta expression are essential for glutamate-stimulated MCP-1 production in the hippocampus. Additionally, our data reveal an anti-inflammatory mechanism of resveratrol involving the inactivation of the ERK1/2 pathway in the hippocampus, which is linked principally to AD-associated cognitive dysfunction.
20050970	0	11	Resveratrol	Chemical	MESH:D000077185
20050970	20	29	glutamate	Chemical	MESH:D018698
20050970	39	69	monocyte chemotactic protein-1	Gene	24770
20050970	99	140	extracellular signal-regulated kinase 1/2	Gene	50689;116590
20050970	152	155	rat	Species	10116
20050970	214	223	glutamate	Chemical	MESH:D018698
20050970	249	268	Alzheimer's disease	Disease	MESH:D000544
20050970	270	272	AD	Disease	MESH:D000544
20050970	334	364	monocyte chemotactic protein-1	Gene	24770
20050970	366	371	MCP-1	Gene	24770
20050970	398	400	AD	Disease	MESH:D000544
20050970	507	516	glutamate	Chemical	MESH:D018698
20050970	520	544	hippocampal inflammation	Disease	MESH:D007249
20050970	575	580	MCP-1	Gene	24770
20050970	645	656	resveratrol	Chemical	MESH:D000077185
20050970	658	689	trans-3,5,4'-trihydroxystilbene	Chemical	-
20050970	707	720	phytostilbene	Chemical	-
20050970	750	755	MCP-1	Gene	24770
20050970	763	772	glutamate	Chemical	MESH:D018698
20050970	820	823	rat	Species	10116
20050970	895	900	MCP-1	Gene	24770
20050970	914	923	glutamate	Chemical	MESH:D018698
20050970	987	992	MCP-1	Gene	24770
20050970	1078	1081	ERK	Gene	24338
20050970	1095	1112	interleukin-1beta	Gene	24494
20050970	1114	1122	IL-1beta	Gene	24494
20050970	1162	1165	ERK	Gene	24338
20050970	1179	1184	SL327	Chemical	MESH:C424127
20050970	1270	1279	glutamate	Chemical	MESH:D018698
20050970	1315	1323	IL-1beta	Gene	24494
20050970	1350	1359	glutamate	Chemical	MESH:D018698
20050970	1382	1387	MCP-1	Gene	24770
20050970	1498	1509	resveratrol	Chemical	MESH:D000077185
20050970	1534	1539	SL327	Chemical	MESH:C424127
20050970	1556	1565	glutamate	Chemical	MESH:D018698
20050970	1574	1582	IL-1beta	Gene	24494
20050970	1624	1629	MCP-1	Gene	24770
20050970	1679	1685	ERK1/2	Gene	50689;116590
20050970	1741	1744	ERK	Gene	24338
20050970	1772	1780	IL-1beta	Gene	24494
20050970	1810	1819	glutamate	Chemical	MESH:D018698
20050970	1831	1836	MCP-1	Gene	24770
20050970	1906	1918	inflammatory	Disease	MESH:D007249
20050970	1932	1943	resveratrol	Chemical	MESH:D000077185
20050970	1978	1984	ERK1/2	Gene	50689;116590
20050970	2044	2046	AD	Disease	MESH:D000544
20050970	2058	2079	cognitive dysfunction	Disease	MESH:D003072
20050970	Negative_Correlation	MESH:C424127	24770
20050970	Negative_Correlation	MESH:D000077185	24494
20050970	Positive_Correlation	MESH:D018698	24770
20050970	Association	MESH:D000544	24770
20050970	Association	116590	24770
20050970	Association	MESH:D018698	MESH:D007249
20050970	Negative_Correlation	MESH:D000077185	MESH:D007249
20050970	Positive_Correlation	24494	24770
20050970	Negative_Correlation	MESH:D000077185	116590
20050970	Association	MESH:D018698	MESH:D000544
20050970	Association	MESH:D000077185	MESH:D003072
20050970	Association	MESH:D003072	116590
20050970	Association	MESH:D000544	116590
20050970	Negative_Correlation	MESH:C424127	MESH:D018698
20050970	Negative_Correlation	MESH:D000077185	24770
20050970	Association	MESH:D000077185	MESH:D000544
20050970	Association	MESH:D003072	50689
20050970	Association	24338	24770
20050970	Negative_Correlation	MESH:C424127	24338
20050970	Negative_Correlation	MESH:D000077185	MESH:D018698
20050970	Association	MESH:D007249	50689
20050970	Negative_Correlation	MESH:D000077185	50689
20050970	Association	MESH:D000544	50689
20050970	Association	MESH:D018698	50689
20050970	Association	MESH:D018698	24338
20050970	Positive_Correlation	MESH:D018698	24494
20050970	Association	24770	50689
20050970	Association	MESH:D018698	116590
20050970	Association	MESH:D007249	116590

